Ischemic Heart Failure clinical trials

Explore recruiting ischemic heart failure clinical trials.

Recruiting ischemic heart failure studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ischemic Heart Failure trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Danish, double-blind, randomized placebo-controlled clinical trial evaluating allogeneic adipose tissue derived mesenchymal stromal cell therapy in patients with recently diagnosed non-ischemic heart failure with reduced ejection fraction.

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

The effect of sacubitril/valsartan versus ramipril on left ventricular function and remodeling in patients with ischemic heart failure with mid-range ejection fraction.

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase I-IIa Trial on the Safety and Preliminary Effectiveness of Intramyocardial Injection of Cardiac Atrial Stem Cells for the Treatment of Advanced Ischemic Heart Failure in Subjects with Ischemic Left Ventricular Dysfunction and Chronic Myocardial Infarction.

Belgium

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Ischemic Heart Failure trials by city

Ischemic Heart Failure clinical trials

Recruiting ischemic heart failure studies right now

Study of Personalized Allocation of Defibrillators in Non-ischemic Heart Failure (SPANISH-1)

Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II

Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Due to HFrEF

Improving Cardiac Rehabilitation Exercise Using Target Heart Rate Trial

CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction

RCT of Implantable Defibrillators in Patients With Non Ischemic Cardiomyopathy, Scar and Severe Systolic Heart Failure

The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)

Development of Novel Physiological CMR Methods in Health and Disease

Revascularization Versus Medical Treatment in Patients With Ischemic Left Ventricular Dysfunction

Randomised Trial of Dual Device Treatment Involving Drug-coated Balloon Angioplasty and Drug-eluting Stent Implantation Compared to Single Device Treatments in Patients With Diabetes Mellitus

Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure

Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock

Also recruiting in Europe

A Danish, double-blind, randomized placebo-controlled clinical trial evaluating allogeneic adipose tissue derived mesenchymal stromal cell therapy in patients with recently diagnosed non-ischemic heart failure with reduced ejection fraction.

The effect of sacubitril/valsartan versus ramipril on left ventricular function and remodeling in patients with ischemic heart failure with mid-range ejection fraction.

A Phase I-IIa Trial on the Safety and Preliminary Effectiveness of Intramyocardial Injection of Cardiac Atrial Stem Cells for the Treatment of Advanced Ischemic Heart Failure in Subjects with Ischemic Left Ventricular Dysfunction and Chronic Myocardial Infarction.

Ischemic Heart Failure trials by city

Other conditions